HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 538 | 650 | 82.8% | |
| HF 4 | 2012 | 568 | 685 | 82.9% | |
| HF 4 | 2013 | 534 | 626 | 85.3% | |
| HF004 | 2014 | 360 | 393 | 91.6% | |
| HF004 | 2015 | 354 | 378 | 93.7% | |
| HF004 | 2016 | 345 | 371 | 93.0% | |
| HF004 | 2017 | 369 | 395 | 93.4% | |
| HF004 | 2018 | 433 | 470 | 92.1% | |
| HF004 | 2019 | 576 | 629 | 91.6% | |
| HF004 | 2020 | 636 | 696 | 91.4% |
